Myths and Facts

Can You Get an STD from a Blood Transfusion?

Receiving a blood transfusion in a modern healthcare setting carries an extremely low risk of STD transmission. In countries with robust blood screening programmes, the residual risk is measured in fractions per million donations. The concern is understandable given historical context — HIV contaminated blood supplies killed thousands before reliable testing existed — but today’s risk profile is fundamentally different from that era.

  • In the US, UK, and most high-income countries, blood donations are screened for HIV, hepatitis B, hepatitis C, syphilis, and other infections

  • The estimated risk of HIV from a screened transfusion in the US is approximately 1 in 1.5 million donations

  • The risk is higher in countries without mandatory blood screening or where screening technology is limited

  • No routine screening covers all possible pathogens — very recent infections may fall within the window period

  • Self-deferral by donors with recent risk factors is a critical additional layer of protection

How Blood Screening Works

In countries with modern blood banking systems, every donation undergoes a battery of mandatory tests before use. In the United States, the FDA requires testing for HIV-1 and HIV-2, hepatitis B (surface antigen and core antibody), hepatitis C, HTLV-I and II, syphilis (Treponema pallidum antibody), West Nile virus, Zika virus, Chagas disease (in some regions), and Babesia (in some regions). Most of these tests use nucleic acid testing (NAT) — a highly sensitive technology that detects the genetic material of the pathogen directly, rather than waiting for the immune system to produce detectable antibodies.

NAT dramatically reduced the window period — the time between infection and when a test can reliably detect it — compared to earlier antibody-only tests. For HIV, the window period for NAT is approximately 9–11 days. For hepatitis C, it is around 7–8 days. Any donation collected within the window period of a recent infection may test negative despite the donor being infectious, which is why donor self-deferral — asking donors to exclude themselves if they have recent risk factors — remains an important layer of protection.

Residual Risk: How Low Is It?

The residual risk of HIV transmission from a screened transfusion in the US is estimated at approximately 1 in 1.47 million donations. For hepatitis C, the estimate is around 1 in 1.1 million. Hepatitis B carries a slightly higher residual risk — approximately 1 in 293,000 donations — because hepatitis B can establish occult (hidden) infection that does not always produce detectable surface antigen. Syphilis risk from transfusion is considered negligible because Treponema pallidum is fragile and does not survive the 4°C storage temperature used for most blood components for more than a few days.

These figures apply to screened blood in high-income countries with robust blood banking infrastructure. In countries without mandatory NAT screening or with limited laboratory capacity, the risk profile is considerably higher.

Infections Not Covered by Standard Screening

Standard blood screening does not cover every possible pathogen. Herpes simplex virus and HPV are not screened for because both are extremely common, latent in a large proportion of the population, and — critically — not transmitted through transfusion in any clinically meaningful way, as they do not circulate freely in blood. Cytomegalovirus (CMV) is a consideration for immunocompromised recipients; CMV-negative or leucodepleted blood is used for high-risk patients. Emerging pathogens — new viruses not yet included in standard panels — represent the hardest-to-eliminate residual risk, as screening cannot be established until a pathogen is identified and a test is developed.

Historical Context: Why the Fear Exists

The concern about STDs from blood transfusions is rooted in a genuine tragedy. Before HIV was identified in 1983 and before reliable HIV testing became available in 1985, a significant proportion of the haemophilia community and other frequent transfusion recipients were infected with HIV through contaminated clotting factors and blood products. In the UK, the infected blood scandal resulted in thousands of deaths from HIV and hepatitis C. Similar catastrophes occurred in the US, France, Canada, Japan, and elsewhere.

This history is real and the harm done was catastrophic. It resulted in significant improvements to blood safety infrastructure globally. The current risk profile — extremely low in screened systems — reflects the changes made in response to these events.

What About Unscreened or Informal Blood Sharing?

Outside formal healthcare settings, blood-to-blood contact carries a much higher STD risk. Sharing needles, syringes, or other injection equipment is a high-efficiency route for HIV, hepatitis B, and hepatitis C transmission. Tattooing or piercing with non-sterile equipment carries similar risks. Unscreened blood transfusions in settings without adequate laboratory infrastructure pose genuine risk. These risks are qualitatively different from screened medical transfusions.

Tips for Blood Recipients

  • Ask about local screening protocols if you are in a country where blood safety standards are uncertain — WHO publishes blood safety data by country.

  • If you received a transfusion before 1990 in most Western countries — particularly if you have not been tested since — consider getting tested for HIV and hepatitis C as a precaution, given the pre-screening era risk.

  • Directed donation is not safer — blood donated by family members or friends is not automatically safer than anonymous blood bank donations and is subject to the same screening requirements.

  • Autologous donation (donating your own blood for a planned procedure) eliminates infectious risk entirely if you are concerned and have a scheduled surgery.

Frequently Asked Questions

Can I get chlamydia or gonorrhea from a blood transfusion?

No. Chlamydia and gonorrhea are bacterial infections that infect specific mucosal tissues. They do not survive in blood in a way that enables transmission through transfusion, and they are not among the infections that blood banking systems screen for because there is no documented transfusion-associated transmission risk.

Can I get herpes from a blood transfusion?

Herpes simplex virus does not transmit through blood transfusion in practice. HSV exists primarily in nerve tissue and mucosal cells, not freely circulating in blood. While HSV DNA can occasionally be detected in blood during primary infection, transmission via transfusion is not documented as a clinical risk.

What should I do if I think I received contaminated blood?

In most high-income countries with mandatory screening, this is extremely unlikely. If you have specific concerns — for example, a transfusion received in a country with limited blood safety infrastructure, or a transfusion before the modern screening era — see your GP and request HIV, hepatitis B, and hepatitis C testing. These infections are all manageable when detected.

Is plasma or platelet donation screened the same way as whole blood?

Yes. All blood components — whole blood, packed red cells, platelets, fresh frozen plasma, and cryoprecipitate — are subject to the same mandatory screening requirements in countries with modern blood banking systems.

Can I donate blood if I have an STD?

It depends on the specific infection. People with HIV are permanently deferred from donation in most countries. Syphilis requires a deferral period after treatment. Chlamydia and gonorrhea do not currently result in deferral in most blood banking systems. Check with your national blood service for current deferral criteria — these rules exist to protect recipients and are updated regularly.

Get Tested If You Have Concerns

If you have questions about a past transfusion or other blood-to-blood contact, HIV and hepatitis testing is straightforward, fast, and confidential. Sexual health clinics and GP practices can run the relevant blood tests, with results typically available within a few days.

Related reading: Can You Donate Blood If You Have an STD? · Understanding HIV · Can You Have an STD With No Symptoms? · Rare STDs You’ve Never Heard Of

Don’t Know What Could Be Causing Your Symptoms?

Get the complete STD test panel and take control of your health!

Dr. Michael Thompson is an expert in sexually transmitted diseases with extensive clinical and research experience. He leads campaigns advocating for early diagnosis and prevention of diseases like HIV and gonorrhea. He collaborates with local organizations to educate both youth and adults about sexual health.